**Jacob Coxon's recent resignation from Anthropic and viral warnings about AI risks have prompted bipartisan congressional interest in regulation, including calls for hearings and references to his statements in discussions of the Ban Artificial Superintelligence Act.** However, as of mid-September 2026, no public U.S. congressional testimony by Coxon has been scheduled before the October 31 deadline. Lawmakers from both parties have urged action on AI safety, yet the legislative calendar, committee processes, and competing priorities create logistical hurdles. Coxon has instead received an invitation to appear before the UK parliament's Business, Innovation, Science and Trade Committee, with media appearances dominating his immediate schedule. These factors support traders' modest lean toward "No," reflecting the gap between calls for oversight and the time required to arrange formal testimony.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated41% chance
NEW
NEW
Oct 31, 2026
41% chance
NEW
NEW
Oct 31, 2026
This market will resolve to "Yes" if Jacob Coxon provides public testimony before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.**Jacob Coxon's recent resignation from Anthropic and viral warnings about AI risks have prompted bipartisan congressional interest in regulation, including calls for hearings and references to his statements in discussions of the Ban Artificial Superintelligence Act.** However, as of mid-September 2026, no public U.S. congressional testimony by Coxon has been scheduled before the October 31 deadline. Lawmakers from both parties have urged action on AI safety, yet the legislative calendar, committee processes, and competing priorities create logistical hurdles. Coxon has instead received an invitation to appear before the UK parliament's Business, Innovation, Science and Trade Committee, with media appearances dominating his immediate schedule. These factors support traders' modest lean toward "No," reflecting the gap between calls for oversight and the time required to arrange formal testimony.
This market will resolve to "Yes" if Jacob Coxon provides public testimony before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.
Market Opened: Sep 9, 2026, 6:33 PM ET
Volume
$16End Date
Nov 1, 2026Market Opened
Sep 9, 2026, 6:33 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if Jacob Coxon provides public testimony before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.**Jacob Coxon's recent resignation from Anthropic and viral warnings about AI risks have prompted bipartisan congressional interest in regulation, including calls for hearings and references to his statements in discussions of the Ban Artificial Superintelligence Act.** However, as of mid-September 2026, no public U.S. congressional testimony by Coxon has been scheduled before the October 31 deadline. Lawmakers from both parties have urged action on AI safety, yet the legislative calendar, committee processes, and competing priorities create logistical hurdles. Coxon has instead received an invitation to appear before the UK parliament's Business, Innovation, Science and Trade Committee, with media appearances dominating his immediate schedule. These factors support traders' modest lean toward "No," reflecting the gap between calls for oversight and the time required to arrange formal testimony.
This market will resolve to "Yes" if Jacob Coxon provides public testimony before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.
“Public testimony” refers to any testimony that is publicly accessible live (in-person or remote) via official livestream, television broadcast, or other live audio/video distribution. Any testimony or deposition that is closed-door or otherwise not publicly accessible will not qualify, even if recordings or transcripts are later released.
The resolution source for this market will be live video or audio of the testimony; however, a consensus of credible reporting may also be used.
Volume
$16End Date
Nov 1, 2026Market Opened
Sep 9, 2026, 6:33 PM ETResolver
0x65070BE91...**Jacob Coxon's recent resignation from Anthropic and viral warnings about AI risks have prompted bipartisan congressional interest in regulation, including calls for hearings and references to his statements in discussions of the Ban Artificial Superintelligence Act.** However, as of mid-September 2026, no public U.S. congressional testimony by Coxon has been scheduled before the October 31 deadline. Lawmakers from both parties have urged action on AI safety, yet the legislative calendar, committee processes, and competing priorities create logistical hurdles. Coxon has instead received an invitation to appear before the UK parliament's Business, Innovation, Science and Trade Committee, with media appearances dominating his immediate schedule. These factors support traders' modest lean toward "No," reflecting the gap between calls for oversight and the time required to arrange formal testimony.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions